| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |